Article
Molecular bases of hprt mutations in malathion-treated human T-lymphocytes.
Mutation research - 2 Feb 1998
Pluth J M, O'Neill J P, Nicklas J A, Albertini R J
Abstract excerpt
Recently, we reported that 6 of 84 (7.1%) hprt mutants arising in in vitro malathion-treated human T-lymphocytes were characterized by specific genomic deletions in a 125-bp region of exon 3 (Pluth et al., Cancer Research 56 (1996) 2393-2399. We have now extended study to determine whether additional differences in molecular spectrum at a basepair level exist between control and malathion-treated mutations, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
